Vesamicol

From WikiMD's Wellness Encyclopedia

Vesamicol

Vesamicol is a compound of notable interest in neuropharmacology due to its unique action on presynaptic terminals, where it modulates the release of the neurotransmitter acetylcholine (ACh). Its peculiar mechanism offers insights into the regulation of neurotransmitter release and has potential therapeutic implications.[1]

Mechanism of Action[edit | edit source]

While many drugs target postsynaptic receptors to modulate neurotransmitter signaling, vesamicol is unique in that it acts presynaptically. Its primary mechanism can be elaborated through the following points:

Inhibition of VAChT: Vesamicol is a non-competitive and reversible antagonist of the VAChT, an essential intracellular transporter. VAChT facilitates the transport of newly synthesized ACh from the cytoplasm into secretory vesicles located within the presynaptic nerve terminal.

Transport and Proton Gradient: The loading of ACh into secretory vesicles by VAChT is driven by a proton gradient, which is established between cell organelles and the cytoplasm. Vesamicol's action interferes with this gradient, thereby blocking the uptake process.

Consequence of ACh Loading Blockade: When vesamicol inhibits the uptake of ACh into the vesicles, these vesicles essentially become "empty". When such vesicles fuse with the neuron membranes in response to a neuronal action potential, the release of ACh into the synaptic cleft is reduced, leading to decreased cholinergic signaling.

Pharmacological Classification[edit | edit source]

Vesamicol can be characterized as a cholinergic physiological antagonist. This is because, while it reduces the effective activity of cholinergic neurons, it does not directly antagonize or block postsynaptic ACh receptors. Instead, its mode of action is upstream of the receptor interaction, emphasizing its presynaptic site of action.

Research and Therapeutic Implications[edit | edit source]

The ability of vesamicol to modulate ACh release can have potential therapeutic applications, especially in disorders characterized by abnormal cholinergic neurotransmission. Furthermore, the compound provides an invaluable tool for neuroscientists to study and dissect the processes of neurotransmitter release and storage at a molecular level.

Conclusion[edit | edit source]

Vesamicol's unique mechanism of action has piqued the interest of the scientific community, offering profound insights into presynaptic regulation of neurotransmission. Its potential therapeutic applications, though still under investigation, could open new avenues in the treatment of neurological and psychiatric disorders.

References[edit | edit source]

[1]


  1. 1.0 1.1
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD